| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/11/2010 | US20100286274 Methods of Diagnosing, Monitoring and Treating Pulmonary Diseases |
| 11/11/2010 | US20100286273 Food supplement |
| 11/11/2010 | US20100286272 Methods Of Use Of Nitroalkene Compositions In Dermatologic Applications |
| 11/11/2010 | US20100286271 Nitro-alkyl Compound Compositions |
| 11/11/2010 | US20100286270 Compositions For The Treatment Of Hoof Diseases |
| 11/11/2010 | US20100286269 Medium-Chain Length Fatty Acids and Glycerides as Nephroprotection Agents |
| 11/11/2010 | US20100286268 Topical composition |
| 11/11/2010 | US20100286267 Compounds for the treatment of metabolic disorders |
| 11/11/2010 | US20100286266 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents |
| 11/11/2010 | US20100286264 Composition comprising a nitrooxyderivative of acetaminophen and a anticonvulsant drug for the treatment of neuropathic pain |
| 11/11/2010 | US20100286263 Gallium complexes with polyalcohols and methods of use |
| 11/11/2010 | US20100286262 Ptgs2 haplotypes |
| 11/11/2010 | US20100286261 Substituted n-acyl homoserine lactones |
| 11/11/2010 | US20100286260 Milnacipran formulations |
| 11/11/2010 | US20100286259 Epoxy-guaiane derivatives and treatment of cancer |
| 11/11/2010 | US20100286256 Compositions and methods for therapy for diseases characterized by defective chloride transport |
| 11/11/2010 | US20100286255 Method for extracting secoisolariciresinol and dihydroquercetin from wood |
| 11/11/2010 | US20100286254 Crystalline forms of dmxaa sodium salt |
| 11/11/2010 | US20100286253 Method for treating ocular neovascularization |
| 11/11/2010 | US20100286252 Human fg01 gene and its applications |
| 11/11/2010 | US20100286251 Mammalian Genes Involved In Viral Infection And Tumor Suppression |
| 11/11/2010 | US20100286249 Micro-RNAS Modulating Immunity and Inflammation |
| 11/11/2010 | US20100286248 Human fg01 gene and its applications |
| 11/11/2010 | US20100286247 Methods of Protection from Oxidative Stress |
| 11/11/2010 | US20100286246 Identification of novel genes coding for small temporal rnas |
| 11/11/2010 | US20100286245 Identification of novel genes coding for small temporal rnas |
| 11/11/2010 | US20100286243 Mig-7 as a specific anticancer target |
| 11/11/2010 | US20100286242 siRNA-Mediated Gene Silencing of Synuclein |
| 11/11/2010 | US20100286241 Compositions comprising k-ras sirna and methods of use |
| 11/11/2010 | US20100286240 MicroRNAs FOR INHIBITING VIRAL REPLICATION |
| 11/11/2010 | US20100286239 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation |
| 11/11/2010 | US20100286238 Suppression of viruses involved in respiratory infection or disease |
| 11/11/2010 | US20100286237 Pro-angiogenic genes in ovarian tumor endothelial cell isolates |
| 11/11/2010 | US20100286236 Dosage of oligonucleotides suitable for the treatment of tumors |
| 11/11/2010 | US20100286235 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 11/11/2010 | US20100286234 Pharmaceutical Composition Comprising Anti-Mirna Antisense Oligonucleotides |
| 11/11/2010 | US20100286233 Peripheral and neural inflammatory crosstalk |
| 11/11/2010 | US20100286232 Microrna expression profile associated with pancreatic cancer |
| 11/11/2010 | US20100286231 Method for identifying a renal fibrosis process use of snail- activity-inhibiting compounds in the production of pharmaceutical compositions, method for identifying said inhibiting compounds, said pharmaceutical compositions and applications thereof |
| 11/11/2010 | US20100286230 Modulation of trpv expression levels |
| 11/11/2010 | US20100286229 Modulation of Androgen Receptor for Treatment of Prostate Cancer |
| 11/11/2010 | US20100286228 Method of inhibiting intimal hyperplasia |
| 11/11/2010 | US20100286227 Compounds from Mycelium of Antrodia Cinnamomea and Use Thereof |
| 11/11/2010 | US20100286226 Combination therapy related to serotonin dual action compounds |
| 11/11/2010 | US20100286225 Diazeniumdiolate compounds, a process for their preparation and pharmaceutical compositions containing them. |
| 11/11/2010 | US20100286224 Method of treating airway diseases with beta-adrenergic inverse agonists |
| 11/11/2010 | US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 11/11/2010 | US20100286222 Use of inhibitors of soluble epoxide hydrolase to synergize activity of cox and 5-lox inhibitors |
| 11/11/2010 | US20100286220 HNF4alpha ANTAGONISTS AND METHODS OF USE |
| 11/11/2010 | US20100286219 1, 3-Dihydroimidazoles for Treating Cardiovascular Disorders |
| 11/11/2010 | US20100286218 Liquid preservative compositions |
| 11/11/2010 | US20100286216 Composition having a high osmotic activity and exhibiting antimicrobial, anti-inflammatory, and regenerative effects |
| 11/11/2010 | US20100286215 Bis-aromatic compounds useful in the treatment of inflammation |
| 11/11/2010 | US20100286214 Tricyclic compounds, compositions and methods |
| 11/11/2010 | US20100286213 Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation |
| 11/11/2010 | US20100286212 Treating and Preventing Viral Infections |
| 11/11/2010 | US20100286211 Oxazolidinone derivatives as antimicrobials |
| 11/11/2010 | US20100286210 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof |
| 11/11/2010 | US20100286209 Vinyl indazolyl compounds |
| 11/11/2010 | US20100286208 Novel polymorph of esomeprazole potassium and process for its preparation |
| 11/11/2010 | US20100286207 Novel 2-Oxo-Heterocyclic Compounds And The Pharmaceutical Compositions Comprising The Same |
| 11/11/2010 | US20100286206 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| 11/11/2010 | US20100286205 Wound care formulation |
| 11/11/2010 | US20100286204 Compound capable of inhibiting 17-beta hydroxysteriod dehydrogenase |
| 11/11/2010 | US20100286203 Pharmaceutically acceptable salts of 2--2h-indazole-7-carboxamide |
| 11/11/2010 | US20100286202 New Compounds |
| 11/11/2010 | US20100286201 Polymorph forms of (s)-2-((4-benzofuranyl)carbonylaminomethyl)-1-((4-(2-methyl-5-(4-fluorophenyl)thiazolyl)carbonyl)piperidine |
| 11/11/2010 | US20100286200 Combination of metformin and an mtp inhibitor |
| 11/11/2010 | US20100286199 Novel fungicides |
| 11/11/2010 | US20100286198 Biofilm-Inhibiting Effect and Anti-Infective Activity of N,C- Linked Arylisoquinolines and the Use Thereof |
| 11/11/2010 | US20100286197 Carboxamide Derivatives As Therapeutic Agents |
| 11/11/2010 | US20100286196 New inhibitor of dd-peptidase and its use as antibiotic or anticancer drug |
| 11/11/2010 | US20100286195 Novel benzooxazol-and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 11/11/2010 | US20100286194 Method for treating addiction |
| 11/11/2010 | US20100286193 Novel Azabicyclo[3.2.1]Oct-2-Ene Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors |
| 11/11/2010 | US20100286192 Non-nucleoside reverse transcriptase inhibitors |
| 11/11/2010 | US20100286191 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators |
| 11/11/2010 | US20100286190 Certain substituted ureas, as modulators of kinase activity |
| 11/11/2010 | US20100286189 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 11/11/2010 | US20100286188 Means for improving cognitive functions and memory based on hydrogenated pyrido(4,3-b)indoles (variants), pharmacological means based thereon and method for the use thereof |
| 11/11/2010 | US20100286187 Method of predicting survival of a non-small-cell lung cancer patient to a chemotherapeutic treatment |
| 11/11/2010 | US20100286186 Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof |
| 11/11/2010 | US20100286185 HCV NS3 Protease Inhibitors |
| 11/11/2010 | US20100286184 Aqueous solution of conophylline and/or conophyllidine |
| 11/11/2010 | US20100286183 Spirohydantoin compounds and methods for the modulation of chemokine receptor activity |
| 11/11/2010 | US20100286182 Hydrazide compounds as thyroid hormone receptor modulators and uses thereof |
| 11/11/2010 | US20100286181 Pyrrole derivatives with antibacterial activity |
| 11/11/2010 | US20100286180 Methods of use of cyclopamine analogs |
| 11/11/2010 | US20100286179 Egfr polymorphisms predict gender-related treatment |
| 11/11/2010 | US20100286178 Compounds and uses thereof |
| 11/11/2010 | US20100286177 Bicyclic amides for the treatment of respiratory depression |
| 11/11/2010 | US20100286174 Inhibiting gsnor |
| 11/11/2010 | US20100286172 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 11/11/2010 | US20100286171 Phenylacetamide derivative |
| 11/11/2010 | US20100286170 (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating |
| 11/11/2010 | US20100286169 Antibacterial Sulfone and Sulfoxide Substituted Heterocyclic Urea Compounds |
| 11/11/2010 | US20100286168 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 11/11/2010 | US20100286167 Dihydroxyphenyl isoindolylmethanones |
| 11/11/2010 | US20100286166 Compositions for the treatment of hyperphenylalaninemia |
| 11/11/2010 | US20100286165 Substituted oxindole compounds |